Under hypoxic conditions, CD44-ICD binds to HIF-2α and activates HIF-2α expression, which further activates HIF-2α target genes, including cyclin D1, Nanog, Oct4, Sox2, and OPN, resulting in the promotion of tumor proliferation and stemness of GSCs. This evidence concerns the gene CD44 and neoplasm.